8-K: CIMG Faces Nasdaq Delisting Threat Over Delayed 10-K Filing

CIMG Inc. received an additional delisting notice from Nasdaq for failing to timely file its Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

Summary

• CIMG Inc. received a letter from Nasdaq on January 22, 2026, indicating non-compliance with Listing Rule 5250(c)(1) due to the failure to timely file its Annual Report on Form 10-K for the fiscal year ended September 30, 2025.
• This failure constitutes an additional basis for potential delisting during the existing Mandatory Panel Monitor period, which was imposed on December 4, 2025, and remains in effect until November 14, 2026.
• The Nasdaq letter does not immediately impact the listing or trading of CIMG's common stock on The Nasdaq Capital Market.
• The company is actively working to complete and file its Form 10-K as soon as practicable.

Sentiment

Score: 2

Explanation: The filing indicates a significant negative event with the company receiving an additional delisting notice from Nasdaq due to non-compliance with filing requirements. This poses a serious threat to its continued listing and investor confidence, with no immediate positive counterpoints.

Negatives

• Receipt of an additional delisting determination letter from Nasdaq.
• Failure to timely file the Annual Report on Form 10-K for the fiscal year ended September 30, 2025.
• Non-compliance with Nasdaq Listing Rule 5250(c)(1).
• The Nasdaq Hearings Panel will consider this as an additional basis for potential delisting.
• Company is under a Mandatory Panel Monitor until November 14, 2026, with a risk of delisting if compliance is not maintained.

Risks

• Risks related to the completion and timing of the company's financial reporting and audit process.
• The possibility that the company may not regain or maintain compliance with Nasdaq listing requirements.
• The risk that the Nasdaq Hearings Panel may determine to delist the company's securities.
• General risks described in the company's filings with the Securities and Exchange Commission.

Future Outlook

CIMG Inc. is working diligently to complete and file its Annual Report on Form 10-K as soon as practicable. The company aims to regain and maintain compliance with Nasdaq listing requirements to avoid delisting, though it acknowledges risks related to the timing of its financial reporting and audit process.

Management Comments

• The Company is working diligently to complete and file its Form 10-K, as soon as practicable.

Industry Context

This event highlights the critical importance of timely financial reporting and regulatory compliance for publicly traded companies, particularly those listed on major exchanges like Nasdaq. Failure to meet these basic requirements can lead to severe consequences, including delisting, which impacts investor confidence and market access. For companies in the digital health and sales development sector, maintaining transparency and adherence to regulatory standards is crucial for attracting and retaining investment.

Stakeholder Impact

• Shareholders: Face increased risk of delisting, which could severely impact the liquidity and value of their investment. Uncertainty regarding the company's financial health and reporting integrity.
• Investors: Potential loss of confidence due to non-compliance and delisting threat.
• Management/Employees: Increased pressure to resolve the filing delay and maintain compliance, potential impact on company reputation and stability.

Next Steps

• CIMG Inc. must complete and file its Annual Report on Form 10-K for the fiscal year ended September 30, 2025.
• The Nasdaq Hearings Panel will consider the additional basis for potential delisting during the ongoing monitor period.
• CIMG Inc. needs to regain and maintain compliance with all Nasdaq listing requirements by November 14, 2026, to avoid delisting.

Key Dates

Recommendation

The receipt of an additional delisting notice from Nasdaq, stemming from a failure to file a crucial annual report (10-K), signals severe operational and governance issues. This non-compliance, especially while already under a mandatory monitoring period, significantly elevates the risk of the company's securities being delisted. Delisting would drastically reduce liquidity and investor access, likely leading to a substantial decline in share price. The lack of timely financial transparency makes it impossible to properly assess the company's financial health, creating extreme uncertainty. Investors should consider a strong sell to mitigate further potential losses given the high probability of negative outcomes.

Keywords

CIMG Inc., Nasdaq, delisting, Form 10-K, non-compliance, financial reporting, SEC filing, listing rules, digital health, sales development, cryptocurrency